Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

Conditions: Type 2 Diabetes Mellitus; Type2diabetes; Diabetes Mellitus, Type 2; Type 2 Diabetes; Diabetes
Interventions: Device: Endogenex System
Sponsors: Endogenex, Inc.
Enrolling by invitation

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 1, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments